Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human IL-17E/IL-25 Antibody, R&D Systems™
Mouse Monoclonal Antibody has been used in 4 publications
Supplier: R&D Systems MAB1258SP
This item is not returnable.
View return policy
Description
IL-17E/IL-25 Monoclonal specifically detects IL-17E/IL-25 in Human samples. It is validated for Western Blot, ELISA, Intracellular Staining by Flow Cytometry, CyTOF-ready.Specifications
IL-17E/IL-25 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, ELISA, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
Q9H293 | |
IL25 | |
E. coli-derived recombinant human IL-17E Tyr33-Gly177 Accession # Q9H293 | |
25 μg | |
Primary | |
Detects human IL-17E in direct ELISAs and Western blots. Shows 100% cross-reactivity with recombinant mouse IL-17E and no cross-reactivity with recombinant human (rh) IL-17, rhIL-17B, rhIL-17C, or rhIL-17F. | |
Human | |
Purified |
Western Blot, ELISA, Flow Cytometry, CyTOF | |
182203 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
IL17E, IL-17E, IL25, IL-25, interleukin 25, Interleukin-17E, interleukin-25 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
64806 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?
Provide Content Correction